Skip to main content

Table 1 Relationship between BIN1 expression and clinicopathological features in HCC.

From: Characterization of Bridging Integrator 1 (BIN1) as a Potential Tumor Suppressor and Prognostic Marker in Hepatocellular Carcinoma

 

Number of

BIN1 expression

 

Clinicopathological variables

each group

Low

High

P

All cases

117

56

61

 

Age (years)

   

0.790

< 50

60

28

32

 

≥50

57

28

29

 

Sex

   

0.019a

Male

101

44

57

 

Female

16

12

4

 

Tumor size (cm in diameter)

   

0.035a

<5

45

16

29

 

≥5

72

40

32

 

Histological differentiation

   

0.011a

Well

20

4

16

 

Moderate

72

36

36

 

Poor

25

16

9

 

Liver cirrhosis

   

0.255

No

48

26

22

 

Yes

69

30

39

 

HBV

   

0.099

Negative

17

5

12

 

Positive

100

51

49

 

Serum AFP

   

0.065

<25 µg/L

30

10

20

 

≥25 µg/L

87

46

41

 

Recurrence (tumor appearing in 5 years)

   

0.725

No

86

42

44

 

Yes

31

14

17

 

Distant metastasis

   

0.0718

No

101

45

56

 

Yes

16

11

5

 
  1. HBV, hepatitis B virus.
  2. aP < 0.05.